| |
Immucor, Inc. is a leading supplier of diagnostic reagents and automated instrumentation to ensure the safety of blood transfusions |
| |
Immucor is publicly traded on NASDAQ under the symbol BLUD with a market value of over $2 billion |
| |
BioArray Solutions Ltd. has pioneered the development of advanced genotyping technology for blood transfusions |
| |
TM Capital assisted Immucor in negotiating and completing the acquisition of BioArray for $117 million in cash |
Press Release
